Publication:
Fructose: a new variable to consider in siadh and the hyponatremia associated with long-distance running?

dc.contributor.coauthorJohnson, Richard J.
dc.contributor.coauthorLee, S.M. Kurt
dc.contributor.coauthorSánchez-Lozada, Laura G.
dc.contributor.coauthorBansal, Anip
dc.contributor.coauthorTolan, Dean R.
dc.contributor.coauthorBjornstad, Petter
dc.contributor.coauthorLanaspa, Miguel A.
dc.contributor.coauthorMaesaka, John
dc.contributor.departmentSchool of Medicine
dc.contributor.kuauthorKanbay, Mehmet
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.date.accessioned2024-11-09T22:59:38Z
dc.date.issued2023
dc.description.abstractFructose has recently been proposed to stimulate vasopressin secretion in humans. Fructose-induced vasopressin secretion is not only postulated to result from ingestion of fructose-containing drinks but may also occur from endogenous fructose production via activation of the polyol pathway. This raises the question of whether fructose might be involved in some cases of vasopressin-induced hyponatremia, especially in situations where the cause is not fully known such as in the syndrome of inappropriate secretion of diuretic hormone (SIADH) and exercise-associated hyponatremia, which has been observed in marathon runners. Here we discuss the new science of fructose and vasopressin, and how it may play a role in some of these conditions, as well as in the complications associated with rapid treatment (such as the osmotic demyelination syndrome). Studies to test the role of fructose could provide new pathophysiologic insights as well as novel potential treatment strategies for these common conditions.
dc.description.indexedbyWOS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.issue1
dc.description.openaccessNO
dc.description.publisherscopeInternational
dc.description.sponsoredbyTubitakEuN/A
dc.description.volume82
dc.identifier.doi10.1053/j.ajkd.2023.01.443
dc.identifier.eissn1523-6838
dc.identifier.issn0272-6386
dc.identifier.quartileQ1
dc.identifier.scopus2-s2.0-85153930388
dc.identifier.urihttps://doi.org/10.1053/j.ajkd.2023.01.443
dc.identifier.urihttps://hdl.handle.net/20.500.14288/7928
dc.identifier.wos1035592200001
dc.keywordsFructose
dc.keywordsHyponatremia
dc.keywordsOsmotic demyelination syndrome
dc.keywordsPolyol pathway
dc.keywordsSIADH
dc.language.isoeng
dc.publisherNational Kidney Foundation
dc.relation.ispartofAmerican Journal of Kidney Diseases
dc.subjectNephrology
dc.subjectKidney diseases
dc.titleFructose: a new variable to consider in siadh and the hyponatremia associated with long-distance running?
dc.typeJournal Article
dspace.entity.typePublication
local.contributor.kuauthorKanbay, Mehmet
local.publication.orgunit1SCHOOL OF MEDICINE
local.publication.orgunit2School of Medicine
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication.latestForDiscoveryd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublication.latestForDiscovery17f2dc8e-6e54-4fa8-b5e0-d6415123a93e

Files